PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-17.49%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-70.11%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-5.29%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
14.79%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
-22.85%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.75%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-27.25%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-30.44%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-9.26%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
14.94%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
-5.71%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
14.27%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
23.49%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-2.01%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
18.76%
Pre-tax margin growth 50-75% of CRWV's 26.86%. Martin Whitman would scrutinize operations.
-4.81%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-0.50%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
20.59%
Similar net margin growth to CRWV's 25.27%. Walter Schloss would investigate industry trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.57%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.11%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.